RADEX
@radexregaffairs.com
RADEX for Regulatory Affairs Consultations and Training Office is a comprehensive and integrated Regulatory Affairs (RA) and Pharmacovigilance consultancy and training office based in Jordan. We take pride in our unique team of highly qualified professionals with extensive knowledge of global regulations and broad experience across different Regulatory Affairs and Pharmacovigilance fields. Founded in 2017, RADEX has provided training, consultancy, and registration services to a growing list of satisfied clients in the pharmaceutical sector worldwide, delivering services with efficiency and professionalism. Our commitment to excellence is reflected in the accreditation of our programs by the Jordan Ministry of Higher Education. Through this accreditation, our Regulatory Affairs and Pharmacovigilance professional training program provides both life sciences graduates and experienced regulatory professionals with comprehensive knowledge of regulatory requirements and submission processes, enabling them to navigate the evolving global regulatory landscape with confidence. At RADEX, we remain committed to supporting the advancement of the pharmaceutical industry while maintaining the highest standards of quality and regulatory compliance in all our services.
RADEX's Company Logos
RADEX's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FEC51F
Lightning Yellow
254, 197, 31
45, 99, 56
0, 22, 88, 0
#A9B8C3
Cadet Blue
169, 184, 195
205, 18, 71
13, 6, 0, 24
#125371
Chathams Blue
18, 83, 113
199, 73, 26
84, 27, 0, 56
About RADEX
RADEX Regulatory Affairs, founded in 2017 in Jordan, is a premier consultancy dedicated to enabling pharmaceutical companies to navigate the intricate landscape of global compliance. Licensed by Philadelphia University and the Jordanian Ministry of Higher Education, RADEX focuses on training programs, consultation, and regulatory services related to pharmaceuticals, medical devices, dietary supplements, and cosmetics. The company offers an array of services including specialized training in Regulatory Affairs and Pharmacovigilance, tailored consultation, product registration, and technical file services.
Under the leadership of CEO Asma Abu-Staiteh, RADEX has successfully registered over 5,000 products and partnered with more than 50 pharmaceutical companies across various regions, including the USA and Europe. The commitment to excellence is reflected in their innovative Pharmacovigilance software and training programs, which ensure compliance with international regulations. RADEX strives to be the most trusted entity in Regulatory Affairs, enhancing the market entry of crucial medical products and contributing to global healthcare advancements.
Company type
Privately Held
Year founded
2017
Company size
2-10 employees
